Is preoperative chemoradiation with paclitaxel and carboplatin a new standard of treatment for esophageal cancer?

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 1, 2013, Pages 16-17

  Adenis, Antoine ^a   Mirabel, Xavier ^a   Mariette, Christophe ^b  

^a CENTRE OSCAR LAMBRET   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; FLUOROURACIL; PACLITAXEL;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; ESOPHAGUS CANCER; HUMAN; LOWER ESOPHAGUS SPHINCTER; LUNG VOLUME; META ANALYSIS (TOPIC); MORBIDITY; NOTE; PREOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; SQUAMOUS CELL CARCINOMA; SURGICAL MORTALITY;

EID: 84876124714     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.11.021     Document Type: Article

References (5)

1. P. Van Hagen, M.C. Hulshof, and J.J. van Lanschot Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 336 2012 2074 2084
2. S.L. Wang, Z. Liao, and A.A. Vaporciyan Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery Int J Radiat Oncol Biol Phys 64 2006 692 699 (Pubitemid 43183562)
3. J.A. Ajani, K. Winter, and R. Komaki Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113 J Clin Oncol 26 2008 4551 4556
4. M. McCurdy, M.F. McAleer, and W. Wei Induction and concurrent taxanes enhance both the pulmonary metabolic response and the radiation pneumonitis response in patients with esophagus cancer Int J Radiat Oncol Biol Phys 76 2010 816 823
5. C. Mariette, J.F. Seitz, and E. Maillard Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: analysis of a randomized controlled phase III trial FFCD 9901 J Clin Oncol 28 2010 15s (abstr 4005)